Exogenous All-<i>Trans</i> Retinoic Acid Induces Myopia and Alters Scleral Biomechanics in Mice-Reference-Cited by-同舟云学术

Exogenous All-Trans Retinoic Acid Induces Myopia and Alters Scleral Biomechanics in Mice

Published:2023-05-23 Issue:5 Volume:64 Page:22
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Brown Dillon M.¹²,Yu Jianshi³,Kumar Praveen³,Paulus Quinn M.²,Kowalski Michael A.⁴,Patel Jay M.¹²⁴,Kane Maureen A.³,Ethier C. Ross¹⁵,Pardue Machelle T.¹²⁵

Affiliation:

1. Department of Biomedical Engineering, Georgia Institute of Technology/Emory University, Atlanta, Georgia, United States

2. Center for Visual and Neurocognitive Rehabilitation, Atlanta Veterans Affairs Healthcare System, Atlanta, Georgia, United States

3. Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland, United States

4. Department of Orthopaedics, Emory University School of Medicine, Atlanta, Georgia, United States

5. Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia, United States

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Reference59 articles.

1. Is myopia a failure of homeostasis?;Flitcroft;Exp Eye Res,2013

2. IMI—report on experimental models of emmetropization and myopia;Troilo;Invest Ophthalmol Vis Sci,2019

3. Myopia and associated pathological complications;Saw;Ophthalmic Physiol Opt,2005

4. The association of refractive error with glaucoma in a multiethnic population;Shen;Ophthalmology,2016

5. On the mechanics of myopia and its influence on retinal detachment;Lakawicz;Biomechanics Model Mechanobiol,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Animal modeling for myopia;Advances in Ophthalmology Practice and Research;2024-11

2. Safety and Tolerability of Anti–microRNA-328 Ophthalmic Solution, SHJ002, in Pediatric Subjects: First-in-Human Clinical Study;Clinical Therapeutics;2024-09